Atrial Fibrillation Screening

Pharmacist-led screening correctly identified most atrial fibrillation cases in the reviewed study. Participants rated atrial fibrillation screening highly and almost all said they would join annual screening. Atrial fibrillation screening with the Kardia Mobile Device was more accurate than pulse palpation. The Kardia device had a lower false-positive rate than pulse palpation. The clinical significance of subclinical AF remains debated. Consenting participants received three consecutive 7-day Holter ECG recordings at planned intervals. Undiagnosed subclinical AF is expected to be less common in a younger general population cohort without established clinical cerebrovascular disease. European Society of Cardiology guidelines recommend AF screening for people aged 75 years or older or at high stroke risk, followed by treatment for positive cases.